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SAVINGS OF THE USE OF RHBMP-2 IN OPEN TIBIA
FRACTURES FOR EUROPEAN HEALTH CARE SYSTEMS FROM
A PAYER AND SOCIETAL PERSPECTIVE
Alt V1, Bentley A2, Schnettler R3
1University Hospital Giessen-Marburg, Site Giessen, Giessen, Germany,
2Abacus International, Bicester, UK, 3University Hospital Giessen,
Location Giessen, Giessen, Germany
OBJECTIVES: Recombinant human bone morphogenetic
protein (rhBMP2) is a growth factor for new bone formation.
The objective was to calculate cost savings for the use of rhBMP-
2 in grade III open tibia fractures for Germany, France and UK
from a public health care system and a societal perspective,
respectively. METHODS: A health economic model was devel-
oped based on clinical data from a previously published ran-
domized controlled trial (BESTT study) comparing rhBMP-2 +
standard of care (soft tissue management and intramedullary
nailing) with standard of care alone. Clinical data were trans-
ferred using reimbursement 2005 tariffs (German-DRG, UK-
NHS, French-Social Security tariffs) and published data for
sickness payments and productivity loss for a one year time
horizon. RESULTS: In Germany and France sickness payments
are provided by public health care insurances and therefore, the
payer perspective is identical to the societal perspective. In
Germany, the use of rhBMP-2 for grade III open tibia fractures
savings of direct costs of 1359 € per patient and of 2714 € for
sickness payment resulting in total savings of 4073 € per patient
that offset the price of rhBMP2 (2950 €). For France, there are
total savings of 3476 € with savings in direct costs of 1197 € and
in indirect costs of 2279 € which outbalance the price of rhBMP-
2. For UK, rhBMP-2 achieves savings of ≤1126 from a payer per-
spective which is below price of rhBMP-2 (≤1790). However,
from a UK societal perspective total savings of ≤5139 make
rhBMP-2 a cost saving strategy. For all three different countries
the major driver for cost savings is the faster fracture healing
with reduced expenses for sickness leave payments and produc-
tivity gain, respectively. CONCLUSION: rhBMP-2 is a cost
saving strategy in grade III open tibia fractures from a payer per-
spective for Germany and France and from a societal perspec-
tive for UK.
METHODS & CONCEPTS
PMC1
FORECASTING WITH TIME SERIES MODELS TO EXAMINE THE
AVAILABILITY OF INPATIENT BEDS
Cerrito PB1, Cerrito JC2
1University of Louisville, Louisville, KY, USA, 2Kroger Pharmacy,
Louisville, KY, USA
OBJECTIVES: To examine the relationship of admissions to dis-
charges in the availability of inpatient beds at a medium sized
southern hospital. METHODS: Data collected from several EDs
were modeled using time series analysis to investigate the rela-
tionship of time of admission to length of stay; in addition, dis-
charge data were collected to examine the time between
admission and discharge to see if the time lag is related to bed
availability. RESULTS: In the emergency department (ED) where
arrivals can occur randomly, the peak time is between 9AM and
5PM in one hospital, increasing the length of stay for non-urgent
patients while patients admitted to inpatient beds have consid-
erable variability in their stay in the ED. At a second hospital,
the peak time occurred at 3PM during the standard time of shift
change. In addition, there is a time lag in beds, with admissions
trailing discharges. CONCLUSION: Time series forecasting can
ﬁnd problems in the availability of beds; once identiﬁed, the
problems can be solved. These time series techniques can be used
to drill down into every 24-hour period to examine where
increased waiting times result for bed unavailability.
PMC2
THE EFFECT OF PHARMACIST CONSULTATION ON 
PATIENT MEDICATION ADHERENCE:AN INSTRUMENTAL
VARIABLE APPROACH
Gu NY1, Hay JW1, Gai YW2
1University of Southern California, Los Angeles, CA, USA, 2Florida
State University,Tallahassee, FL, USA
OBJECTIVES: To assess the effectiveness of pharmacist consul-
tation service in increasing patient medication adherence by
applying the instrumental variable (IV) method to adjust for
endogeneity. METHODS: This study used the Kaiser Permanente
(KP) pharmacist consultation intervention survey data from
1993 to 1995. The effect of pharmacist consultation on med-
ication adherence was measured via patients’ satisfaction with
the service using patient ratings. Treating this variable as exoge-
nous, a single-equation probit model was used. To address the
endogeneity, bivariate probit models were employed using dif-
ferent sets of instrumental variables (IVs). The IVs used were
measures of patients’ optimism, as well as the business of a KP
pharmacy by measuring the amount of prescriptions ﬁlled at
non-KP pharmacies. Smith-Blundell test was used to test the
endogeneity. Over-identiﬁcation tests were used to test the valid-
ity of the IVs. The weak instrument test was used to evaluate the
IVs’ explanatory powers. RESULTS: All tests indicated that the
IVs used were valid and the results were signiﬁcant. The single-
equation probit model renders that patients’ satisfaction with
pharmacist consultation has signiﬁcant effect on medication
adherence (p < 0.0001). The bivariate probit models using dif-
ferent sets of IVs exhibit that the single-equation probit model
underestimated the magnitude of the effect because of the endo-
geneity bias; the marginal effect of patients’ satisfaction with
pharmacist consultation on medication adherence increased
from 0.06 to about 0.27 after using bivariate probit models 
(p < 0.0001). In other words, once the endogeneity bias was cor-
rected, pharmacist consultation demonstrated a greater impact
on patient medication adherence. CONCLUSION: Pharmacist
consultation plays a signiﬁcant role in health care. Its effect can
be evaluated on patient medication adherence via patient satis-
faction with the service. This study reveals that the effect of this
service was signiﬁcant before addressing the endogeneity and, the
magnitude of the effect increased after the endogeneity was
removed.
PMC4
DEVELOPING NATIONS AND COST-EFFECTIVENESS:
THE METHODS MATTER
Singer ME, Rose J
Case Western Reserve University, Cleveland, OH, USA
OBJECTIVES: Examine the impact of adjusting for price differ-
ences (conversion to international dollars), as advocated by the
World Health Organization (WHO), when conducting cost-
effectiveness analyses in developing nations. METHODS: We
created a hypothetical cost-effectiveness analysis, set in India,
with 2 strategies: standard care (STD-CARE) and intervention.
Two costing methods were used: unadjusted exchange rate
(XCHG), and international dollars (I$) where non-traded goods
(e.g. services or locally traded goods) and per-capita gross
domestic product (GDP) were adjusted for international price
differences using purchasing power parity (PPP) estimates from
WHO. Three different interventions were considered: 1) Costs
are all internationally traded goods (TRADED); 2) Costs are all
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non-traded goods (NON-TRADED); and 3) Costs evenly split
between traded and non-traded goods (MIX). STD-CARE costs
freely varied from 0–100% traded goods. GDP was about $600
using the exchange rate, I$1865 using PPP. The outcome measure
was the incremental cost-effectiveness ratio stated as multiples
of GDPs/DALY (Disability-adjusted Life Year). We considered
the commonly used threshold of 1GDP, as well as WHO rec-
ommendations: ≤1GDP “very cost-effective”, 1–3GDP “cost-
effective”. Parameters were chosen to achieve an ICER of 4GDP
for XCHG. RESULTS: By deﬁnition, the ICER is constant
(4GDP) for XCHG. For NON-TRADED using $I, the ICER was
≥4GDP in all cases. For TRADED using I$, the ICER was <1
when <79% of STD-CARE costs were traded goods. For MIX
using I$, ICERs were never below 1GDP, but were below 3GDP
when <76% of STD-CARE costs were traded goods. CON-
CLUSION: Adjusting prices using purchasing power parity (I$’s)
as opposed to the unadjusted ofﬁcial exchange rate can dramat-
ically alter conclusions when comparing interventions involving
different proportions of traded goods. In particular, an inter-
vention with costs primarily from traded goods (e.g. vaccination)
may be clearly not cost-effective using the exchange rate, yet
appear very cost-effective after adjusting for purchasing power
parity.
PMC5
EVALUATING AN ONLINE CALCULATOR FOR ANALYZING
INCREMENTAL NET BENEFIT AND THE EXPECTED VALUE OF
PERFECT INFORMATION FROM PATIENT LEVEL DATA
McGhan WF,Tundia N, Quadri H,Viswanathan S, Peterson AM
University of the Sciences in Philadelphia, Philadelphia, PA, USA
OBJECTIVES: To evaluate an online calculator for analyzing
incremental net beneﬁt and expected value of perfect informa-
tion. METHODS: An online calculator was developed that 
generates incremental net beneﬁt (INB) and expected value of
perfect information (EVPI) statistics and graphs from patient
level cost and effectiveness data and is freely available at
http://www.HealthStrategy.com. The calculator was compared
to two other software options: Obenchain’s ICEplane software
which can be downloaded from http://www.math.iupui.edu/
~indyasa/bobdown.htm and an MS Excel module developed by
Nixon, Wonderling and Grieve, and downloadable through
http://www.mrc-bsu.cam.ac.uk. For the comparison, three
datasets were utilized from published studies dealing with 
ﬂuoxetine (FLUX), a randomized test dataset (RND), and
acupuncture (ACCU). RESULTS: INB values on the three
datasets at various lambda threshold values (WTP) between
HealthStrategy, ICEplane and Nixon were as follows: ACCU
(WTP at mean ICER, 10088): 2.0 vs 2.7 vs 2.0; RND (WTP at
1.0): 2.0 vs 2.4 vs 2.0; and FLUX (WTP at 1742): 57472 vs
56570 vs 56979. ICEplane does not calculate EVPI, but the
Nixon module was adapted by adding a column for the estima-
tion of the unit normal loss integral as documented by Grifﬁn
and Chilcott. The respective HealthStrategy and Nixon module
EVPI values for each dataset were as follows: ACCU (WTP at
mean ICER): 67.9 vs 66.7; RND (WTP at 0.0): 0.167 vs 0.105;
and FLUX (WTP at 0.0): 169.8 vs 169.8. CONCLUSION: All
three software provide basic statistics and graphs including
scatter plots, conﬁdence intervals and acceptability curves. For
INB and EVPI, the HealthStrategy and Nixon packages use para-
metric calculations requiring assumptions not always met with
cost effectiveness data. For future research, more comprehensive
software should be added to this comparison like Stata, the R
statistical package and Winbugs, along with consideration of
population EVPI and expected value of sample information
(EVSI).
PMC6
A COST-EFFECTIVENESS STUDY OF TRANSPORTING
PERSONS WITHOUT MEDICAL NEEDS BY AMBULANCE.A
PROSPECTIVE STUDY OF AMBULANCE SERVICE IN SWEDEN
Karlberg HI1, Beillon LM2, Suserud BO3, Herlitz J1
1Gothenburg University, Gothenburg, SE, Sweden, 2Nordic School of
Public Health, Gothenburg, SE, Sweden, 3Högskolan i Borås, Borås, SE,
Sweden
OBJECTIVES: Overuse of emergency services and overcrowding
of A&E departments is a major problem. Many patients suffer-
ing from minor illness or injuries often call the emergency dis-
patch centre requesting an ambulance for transport to a hospital,
where this is included in the welfare package as in most OECD
countries. The aim of this study was to analyze the characteris-
tics of patients transported by ambulance, and assess the appro-
priateness related to age, sex, diagnoses, and urban or rural areas
respectively. METHODS: This study was prospective, cross sec-
tional in urban and rural districts in Sweden. Assessments made
by the emergency medical dispatch operators for 1977 consecu-
tive users of ambulance, were reviewed and evaluated by the
ambulance staffs on the scene at the end of the pre-hospital care.
RESULTS: Assessment made by the ambulance staff indicated
that a majority of people transported by the ambulance service
had no medical needs for prehospital interventions. There was a
substantial safety margin in the priority assessments. Only ten
percent had potentially life threatening conditions. In urban
areas one third of the patients for whom an ambulance were
assigned did not need the ambulance service. Several of these
were ordered by hospital staff for transportation of elderly
patients to other providers. In the more sparsely populated areas
the medical status of the patients generally was more severe,
more medical treatment was given in the ambulances, and the
ambulances was more frequently judged as the appropriate mode
of transport in these regions. CONCLUSION: Due to the safety
aspects, there is an overuse of ambulance services increasing the
need for back-up vehicles. This means that there are no marginal
costs, while the marginal utility is decreasing. For this we have
a formula.
PMC7
A PRE-POST TIME IN MOTION METHODOLOGY TO EXAMINE
PRODUCT WASTAGE REDUCTION: PILOT RESULTS IN
MAGNETIC RESONANCE CONTRAST MEDIA PHARMACY
BULK PACK
Guo A1, Doyle J2, Stern L2, Chen Y2, Etschmaier M2
1Berlex Laboratories, Wayne, NJ, USA, 2Analytica International, New
York, NY, USA
OBJECTIVES: To demonstrate the applicability of time in
motion methodology in detecting difference in MR contrast
media wastage and the potential costs savings of magnetic reso-
nance (MR) contrast media Pharmacy Bulk Pack (PBP) use.
METHODS: Time in motion methodology has been demon-
strated as an effective tool in highlighting efﬁciencies in process-
oriented tasks and increasingly used in health care to measure
efﬁciency. We designed a prospective, time in motion study to
examine the pre and post use of MR contrast media PBPs. Seven
MR imaging centers collected 30 continuous observations (for
approximately 2 weeks). During the pre period, data were col-
lected via a quantitative Case Report Form on the time and
number of MR procedures, patient weight, body part scanned,
contrast media details (volume used, packages opened, volume
discarded), and total scan time. MR center-speciﬁc contrast
media usage algorithms, which incorporated gadopentetate
dimeglumine PBP, were developed based on data collected in the
pre-period to enhance efﬁciency and reduce wastage, and were
